AI assistant
Gland Pharma Limited — Call Transcript 2022
Oct 11, 2022
59319_rns_2022-10-11_65c0bfaa-4fc6-41d5-8170-0835dfcba595.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [59 x 48] intentionally omitted <==
==> picture [298 x 20] intentionally omitted <==
October 11, 2022
BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25[th] floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245
National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor Plot no. C-1, Block G, Bandra Kurla Complex Bandra (East), Mumbai - 400 051 Symbol: GLAND (ISIN: INE068V01023)
Dear Sir/Madam,
Sub: Earnings Conference Call
We hereby inform you that the Earnings Call for Investors/Analysts will be held on Wednesday, October 26, 2022 at 18:30 hours (IST) for 60 minutes to discuss the Company's financial performance and business updates for the Second quarter ended September 30, 2022. The details of the Earnings Call for Investors/Analysts are enclosed.
The transcript and the audio recording of the Earnings Call will be made available on the Company’s website.
This is for your information and records.
Yours truly,
For Gland Pharma Limited
SAMPATH Digitally signed by SAMPATH KUMAR PALLERLAMUDI KUMAR DN: cn=SAMPATH KUMAR PALLERLAMUDI, c=IN, o=Personal, PALLERLAMUDI email=[email protected]: 2022.10.11 11:58:51 +05'30'
P Sampath Kumar Company Secretary and Compliance Officer
==> picture [580 x 78] intentionally omitted <==
==> picture [69 x 51] intentionally omitted <==
EARNINGS CONFERENCE CALL
The Company will host Earnings conference call for second quarter of FY’23 on October 26th 2022, at 18:30 hours (IST) , during which the management team will discuss the financial performance and take questions. Audio record and Transcript of the conference call will be available at www.glandpharma.com.
| Earnings Conference Dial-In Information | Earnings Conference Dial-In Information | ||
|---|---|---|---|
| Diamond pass link | Click**here**to register | ||
| Universal Access | +91 22 6280 1516 | ||
| +91 22 7115 8875 | |||
| National Toll Free | 1 800 120 1221 | ||
| USA – 18667462133 | |||
| International Toll-Free Number | UK – 08081011573 | ||
| Singapore – 8001012045 | |||
| Hong Kong–800964448 | |||
| USA + 1 3233868721 | |||
| UK + 44 2034785524 | |||
| International Toll Number | Singapore + 65 31575746 | ||
| Hong Kong + 852 30186877 |
Playback of the earnings call will be available after the end of the call on the following number:
| Dial-in Number | Access code | Replay Dates | ||
|---|---|---|---|---|
| India (+91 22 71945757) | ||||
| Hong Kong (800965553)Singapore (8001012510)UK (8007563427) | 62081 | October 26th2022, tillNovember 2nd2022 | ||
| USA(18332898317) |
Contact:
Sumanta Bajpayee Vice President – Corporate Finance & Investor Relations E- Mail: [email protected] and [email protected]